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Abstract
Motivation: Prediction of functional variant consequences is an important part of sequencing pipe-
lines, allowing the categorization and prioritization of genetic variants for follow up analysis.
However, current predictors analyze variants as isolated events, which can lead to incorrect predic-
tions when adjacent variants alter the same codon, or when a frame-shifting indel is followed by a
frame-restoring indel. Exploiting known haplotype information when making consequence predic-
tions can resolve these issues.
Results: BCFtools/csq is a fast program for haplotype-aware consequence calling which can take
into account known phase. Consequence predictions are changed for 501 of 5019 compound vari-
ants found in the 81.7M variants in the 1000 Genomes Project data, with an average of 139 com-
pound variants per haplotype. Predictions match existing tools when run in localized mode, but the
program is an order of magnitude faster and requires an order of magnitude less memory.
Availability and Implementation: The program is freely available for commercial and non-
commercial use in the BCFtools package which is available for download from http://samtools.
github.io/bcftools.
Contact: pd3@sanger.ac.uk
Supplementary information: Supplementary data are available at Bioinformatics online.
1 Introduction
With the rapidly growing number of sequenced exome and whole-
genome samples, it is important to be able to quickly sift through
the vast amount of data for variants of most interest. A key step in
this process is to take sequencing variants and provide functional ef-
fect annotations. For clinical, evolutionary and genotype-phenotype
studies, accurate prediction of functional consequences can be crit-
ical to downstream interpretation. There are several popular exist-
ing programs for predicting the effect of variants such as the
Ensembl Variant Effect Predictor (VEP) (McLaren et al., 2016),
SnpEff (Cingolani et al., 2012) or ANNOVAR (Wang et al., 2010).
One significant limitation is that they are single-record based and, as
shown in Figure 1, this can lead to incorrect annotation when sur-
rounding in-phase variants are taken into account.
With recent experimental and computational advancements,
phased haplotypes over tens of kilobases are becoming routinely
available through the reduced cost of long-range sequencing tech-
nologies (Zheng et al., 2016) and the increased accuracy of statis-
tical phasing algorithms (Loh et al., 2016; Sharp et al., 2016) due to
the increased sample cohort sizes (McCarthy et al., 2016). We pre-
sent a new variant consequence predictor implemented in BCFtools/
csq that can exploit this information.
2 Materials and methods
For haplotype-aware calling, a phased VCF, a GFF3 file with gene
predictions and a reference FASTA file are required. The program
begins by parsing gene predictions in the GFF3 file, then streams
through the VCF file using a fast region lookup at each site to find
overlaps with regions of supported genomic types (exons, CDS, UTRs
or general transcripts). Active transcripts that overlap variants being
annotated are maintained on a heap data structure. For each
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transcript we build a haplotype tree which includes phased genotypes
present across all samples. The nodes in this tree correspond to VCF
records with as many child nodes as there are alleles. In the worst case
scenario of each sample having two unique haplotypes, the number of
leaves in the haplotype tree does not grow exponentially but stops at
the total number of unique haplotypes present in the samples. Thus
each internal node of the tree corresponds to a set of haplotypes with
the same prefix and the leaf nodes correspond to a set of haplotypes
shared by multiple samples. Once all variants from a transcript are
retrieved from the VCF, the consequences are determined on a spliced
transcript sequence and reported in the VCF.
Representing the consequences is itself a challenge as there can be
many samples in the VCF, each with different haplotypes, thus making
the prediction non-local. Moreover, diploid samples have two haplo-
types and at each position there can be multiple overlapping transcripts.
To represent this rich information and keep the output compact, all
unique consequences are recorded in a per-site INFO tag with structure
similar to existing annotators. Consequences for each haplotype are re-
corded in a per-sample FORMAT tag as a bitmask of indexes into the
list of consequences recorded in the INFO tag. The bitmask interleaves
each haplotype so that when stored in BCF (binary VCF) format, only
8 bits per sample are required for most sites. The bitmask can be trans-
lated into a human readable form using the BCFtools/query command.
Consequences of compound variants linking multiple sites are reported
at one of the sites only with others referencing this record by position.
3 Results
3.1 Accuracy
Accuracy was tested by running in localized mode and comparing
against one of the existing local consequence callers (VEP) using
gold-standard segregation-phased NA12878 data (Cleary et al.,
2014). With each site treated independently, we expect good agree-
ment with VEP at all sites. Indeed, only 11 out of 1.6M predictions
differed within coding regions. See the Supplement (S2) for further
details about these differences. Detailed comparison between VEP
and other local callers is a topic that has been discussed elsewhere
(McCarthy et al., 2014).
3.2 Performance
Performance was compared to VEP (McLaren et al., 2016), SnpEff
(Cingolani et al., 2012) and ANNOVAR (Wang et al., 2010) run-
ning on the same NA12878 data. In localized and haplotype-aware
mode, BCFtools/csq was faster by an order of magnitude than the
fastest of the programs and required an order of magnitude less
memory, see Supplementary Table S1. In contrast to localized call-
ing, scaling of haplotype-aware calling will depend on the number
of samples being annotated. In Supplementary Figures S2–S5, we
show that memory and time both scale linearly with number of sites
in the transcript buffer and number of samples.
3.3 Compound variants in 1000 Genomes
Applied to the 1000 Genomes Phase 3 data, haplotype-aware conse-
quence calling modifies the predictions for 501 of 5019 compound
variants, summarized in Table 1 and discussed in the Supplement
S3. On average, we observe 139.4 compound variants per haplotype
(Supplementary Fig. S1), recover 16.4 variants incorrectly predicted
as deleterious, and identify 0.8 newly deleterious compound variants
per haplotype.
To highlight an example, a frame-restoring pair of indels in the
DNA-binding protein gene SON was found to be monomorphic
across all 1000 Genomes samples. There, a 1-bp insertion followed
by a 1-bp deletion (G>GA at 21:34 948 684 and GA>G at 21:34
948 696) are each predicted as frame-shifting, but in reality the com-
bined effect is a substitution of four amino acids. The functional
consequence is therefore likely much less severe, consistent with the
SON gene being highly intolerant of loss-of-function mutations, as
predicted by ExAC (Lek et al., 2016).
In most studies haplotypes have been determined statistically.
Given the typical 1% switch error rate, we estimate the compound
error rate from the distribution of heterozygous genotypes in com-
pound variants to be 1.1%, see the Supplement S4 for details.
4 Discussion
Correctly classifying the functional consequence of variants in the
context of nearby variants in known phase can change the
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Fig. 1. Three types of compound variants that lead to incorrect consequence prediction when handled in a localized manner, i.e. each variant separately rather
than jointly. (A) Multiple SNVs in the same codon result in a TAG stop codon rather than an amino acid change. (B) A deletion locally predicted as frame-shifting
is followed by a frame-restoring variant. Two amino acids are deleted and one changed, the functional consequence on protein function is likely much less se-
vere. (C) Two SNVs separated by an intron occur within the same codon in the spliced transcript. Unchanged areas are shaded for readability. All three examples
were encountered in real data (Color version of this figure is available at Bioinformatics online.)
Table 1. Summary of BCFtools/csq consequence type changes
from localized (rows) to haplotype-aware (columns) calling in 1000
Genomes data
Note: Blue/orange background indicates a change to a less/more severe pre-
diction in haplotype-aware calling. Only variants with modified predictions
are included in the table. (Color version of this table is available at
Bioinformatics online.)
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interpretation of their effect. Variants previously flagged as benign
or less severe may now be flagged as deleterious and vice versa. In a
rare disease sequencing study, for example, this may have a signifi-
cant impact as these functional annotations may determine which
variants to follow up for further study.
Previous work by Wei et al. (2015) does not consider indels or
introns occurring within the same codon, and requires access to the
BAM alignment files to estimate haplotypes. Our approach starts
with phased VCF data, leaving haplotype calling as a problem to be
solved by other means, for example by statistical phasing. Instead,
we focus on providing fast consequence prediction taking into ac-
count all variation within a transcript.
The standard programs have rich functionality beyond the report-
ing of variant consequence, and the aim of BCFtools/csq is not to
compete with that. Instead, we propose haplotype-aware calling is
included in annotation pipelines for enhanced downstream analysis.
Acknowledgements
The authors thank Monica Abrudan, Richard Durbin, Daniel Gaffney, Thomas
Keane, William McLaren and Kim Wong for helpful discussions and ideas.
Funding
The work was supported by the Wellcome Trust (WT098051) and a grant co-
funded by the Wellcome Trust and Medical Research Council (WT098503).
Conflict of Interest: none declared.
References
Cingolani,P. et al. (2012) A program for annotating and predicting the effects
of single nucleotide polymorphisms. SnpEff Fly (Austin), 6, 80–92.
Cleary,J.G. et al. (2014) Joint variant and de novo mutation identification on
pedigrees from high-throughput sequencing data. J. Comput. Biol., 21,
405–419.
Lek,M. et al. (2016) Analysis of protein-coding genetic variation in 60,706
humans. Nature, 536, 285–291.
Loh,P. et al. (2016) Reference-based phasing using the Haplotype Reference
Consortium panel. Nat. Genet., 48, 1443–1448.
McCarthy,D. et al. (2014) Choice of transcripts and software has a large effect
on variant annotation. Genome Med., 6, 26.
McCarthy,S. et al. (2016) A reference panel of 64,976 haplotypes for genotype
imputation. Nat. Genet., 48, 1279–1283.
McLaren,W. et al. (2016) The Ensembl variant effect predictor. Genome
Biol., 17, 122.
Sharp,K. et al. (2016) Phasing for medical sequencing using rare variants and
large haplotype reference panels. Bioinformatics, 32, 1974–1980.
Wang,K. et al. (2010) ANNOVAR: functional annotation of genetic variants
from high-throughput sequencing data. Nucleic Acids Res., 38, e164.
Wei,L. et al. (2015) MAC: identifying and correcting annotation for multi-
nucleotide variations. BMCGenomics, 16, 569.
Zheng,G.X. et al. (2016) Haplotyping germline and cancer genomes with
high-throughput linked-read sequencing. Nat. Biotechnol., 34, 303–311.
BCFtools/csq 2039
